HuagongsheHuagongshe Chemistry Print Report · For research reference only
Aspirin → HCID 178427217, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Aspirin | HCID 2244 | — |
| Reactant | Celecoxib | HCID 2662 | — |
| Reactant | Ibuprofen, (+-)- | HCID 3672 | — |
| Reactant | Indomethacin | HCID 3715 | — |
| Reactant | Mefenamic Acid | HCID 4044 | — |
| Reactant | Rofecoxib | HCID 5090 | — |
| Product | HCID 178427217 | HCID 178427217 | — |
Reaction Steps
acetyl salicylic acid (ortho-acetoxybenzoic acid), mefenamic acid (2-[(2,3-Dimethylphenyl)amino]benzoic acid); ibuprofen (α-methyl-4-(2-methylpropyl)-benzeneacetic acid); indomethacin (1-(p-chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic acid); and rofecoxib (4-[4-(methylsulfonyl)phenyl]-3-phenyl- 2(5H)-furanone, for example, Vioxx®, sold by Merck) and celecoxib (4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide, for example, Celebrex® sold by Pfizer.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US07129374B2 |
| Source dataset | uspto-grants-2006_10 |
| ORD ID | ord-751b7506e6cc4a17a243c48b4338c51a |
| Source note | uspto-grants-2006_10 |